세계의 재생 의료 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 치료법별, 재료별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Regenerative Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy, By Material, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1785163
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 재생 의료 시장 규모는 2024년에 146억 7,000만 달러가 되었고, 2030년까지의 예측 기간의 CAGR은 9.45%를 나타내, 눈부신 성장이 예상되고 있습니다.
재생 의학은 손상된 인간의 장기와 조직의 대체 및 재생에 중점을 둔 새로운 분야입니다. 이 치료법에서는 줄기세포를 이용하여 자연치유가 불가능한 조직이나 장기의 기능을 회복시킵니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
146억 7,000만 달러
시장 규모 : 2030년
250억 2,000만 달러
CAGR : 2025-2030년
9.45%
급성장 부문
조직 공학
최대 시장
북미
예를 들어 미국암협회의 추계에 따르면 2023년에는 미국에서 약 195만 8,310명의 신규암 환자와 60만 9,820명의 암 관련 사망자가 보고되어 시장 성장을 견인했습니다. 과학자들은 이 치료법에 의해 기관과 조직을 실험실에서 증식시켜 인체에 안전하게 이식할 수 있을 것으로 기대하고 있습니다. 재생 의료 수요는 기존의 치료에 비해 보다 효과적인 상태 관리를 제공하는 개인화된 치료 접근법에 의해 빠르게 증가하고 있습니다. 재생 의료는 인공 장기, 세포 치료, 조직 공학 등 다양한 의료 기술을 포함합니다. 조직 공학과 생체 재료는 신체 조직의 형성을 촉진하기 위해 신체에 이식되는 비계를 사용합니다. 이 비계는 줄기 세포를 끌어들이고 원하는 형태의 조직의 개발을 촉진합니다. 세포치료는 치수, 지방, 골격근, 혈액, 골수 등에서 채취한 줄기세포를 이용하여 체내 손상된 조직을 복구합니다. 의료기기와 인공장기는 신체에서 기능장애에 빠진 장기를 지원합니다.
주요 시장 성장 촉진요인
R&D 활동에 대한 투자 증가
주요 시장 과제
세포 및 유전자 치료 벡터의 신뢰성 부족
주요 시장 동향
신흥국의 잠재력 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 재생 의료 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
치료법별(줄기세포 치료, 유전자 치료, 조직 공학, 소분자 및 생물학적 치료)
재료별(합성 소재, 생물학적 유래 소재, 유전자 조작 소재 및 의약품)
용도별(심혈관, 종양학, 근골격계, 상처 치유, 안과 및 기타 및 기타)
최종 사용자별(병원, 전문센터, 학술 및 연구 기관)
지역별
기업별(2024년)
시장 맵
제6장 북미의 재생 의료 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 재생 의료 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 재생 의료 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 재생 의료 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 재생 의료 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
제13장 세계의 재생 의료 시장 : SWOT 분석
제14장 경쟁 구도
Stryker Corporation
Athersys, Inc.
Integra Lifesciences Corporation
Isto Biologics(Isto Biologics Medical Systems, Inc.)
Organogenesis Inc.
CryoLife, Inc.
Medtronic plc
US Stem Cell, Inc.
Zimmer Biomet Holdings, Inc.
3M Company
제15장 전략적 제안
제16장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Regenerative Medicine Market was valued at USD 14.67 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.45% through 2030F. Regenerative medicine is an emerging discipline that focuses on the replacement or regeneration of damaged human organs or tissues. This therapeutic approach utilizes stem cells to restore function to tissues and organs that are unable to heal themselves.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 14.67 Billion
Market Size 2030
USD 25.02 Billion
CAGR 2025-2030
9.45%
Fastest Growing Segment
Tissue Engineering
Largest Market
North America
For instance, according to estimates from the American Cancer Society, approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths were reported in the U.S. in 2023, driving growth in the market. Scientists anticipate that this therapy will enable the laboratory growth of organs and tissues, which can then be safely implanted into the human body. The demand for regenerative medicine is rapidly increasing due to its personalized treatment approach, which provides more effective management of conditions compared to conventional treatments. Regenerative medicine encompasses a range of medical techniques, including artificial organs, cellular therapies, and tissue engineering. Tissue engineering and biomaterials employ scaffolds that are implanted in the body to facilitate the formation of new tissue. These scaffolds attract stem cells, promoting the development of tissue with the desired shape. Cellular therapies utilize stem cells derived from dental pulp, fat, skeletal muscle, blood, bone marrow, and other sources to repair damaged tissues within the body. The medical devices and artificial organs offer support to failing organs within the body.
Key Market Drivers
Increasing Investments in R&D Activities
Increasing investments in research and development (R&D) activities have propelled market growth by driving innovative product launches. This surge in investments has led to comprehensive R&D initiatives, with numerous start-up companies receiving funding for the development of novel therapies and products. Consequently, this has facilitated significant collaborations, mergers, and partnerships aimed at maximizing the mutual benefits of R&D activities. In June 2022, Galapagos, a Belgian biotech company, announced its acquisition of Cell Point and Abound Bib. This strategic move aims to expedite the development and commercialization of next-generation cell therapies. With the integration of Cell Point and Abound Bio, Galapagos will gain access to innovative, scalable, decentralized, and automated point-of-care cell therapy supply models, as well as a cutting-edge fully human antibody-based therapeutics platform. Together, these advancements position Galapagos as a fully integrated biopharmaceutical company with the potential to disrupt the CAR-T treatment paradigm. Apart from private entities, various governments and government-funded research institutes are actively investing in this industry to introduce effective treatment options for chronic diseases like cancer, Parkinson's disease, diabetes, renal diseases, cardiovascular diseases, and others. In January 2022, the Royal College of Surgeons in Ireland secured USD 226,000 in funding from the European Commission for the development of antioxidant-ion substituted nanoparticles for osteoporotic bone treatment.
Key Market Challenges
Lack of Reliable Vector Production for Cell and Gene Therapy
Current methods of vector production often have limitations in terms of scalability. Producing enough high-quality vectors to meet the demands of clinical trials and potential commercialization can be challenging, especially for therapies with large patient populations. As regenerative medicine advances, the diversity of therapeutic approaches and vector types increases. Developing reliable vector production methods for various vectors, including adeno-associated viruses (AAVs) and lentiviruses, is crucial to accommodate this diversity.
Key Market Trends
Increase In Potential in Emerging Economies
Developing economies hold significant potential in the regenerative medicine market, driven by the rising prevalence of traumatic injuries and organ transplantations worldwide. Key industry players have strategically analyzed the opportunities in tissue engineering and regenerative medicine within these economies, leveraging various developmental strategies such as product launches, approvals, agreements, partnerships, and mergers. Despite ethical challenges arising from unfavorable norms, it is anticipated that developing economies will embrace tissue-engineering and regeneration technology.
Key Market Players
Stryker Corporation
Athersys, Inc.
Integra Lifesciences Corporation
Isto Biologics (Isto Biologics Medical Systems, Inc.)
Organogenesis Inc.
CryoLife, Inc.
Medtronic plc
U.S. Stem Cell, Inc.
Zimmer Biomet Holdings, Inc.
3M Company
Report Scope:
In this report, the Global Regenerative Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Regenerative Medicine Market, By Therapy:
Stem Cell Therapy
Gene Therapy
Tissue Engineering
Small Molecule & Biologic
Regenerative Medicine Market, By Material:
Synthetic Material
Biologically Derived Material
Genetically Engineered Material
Pharmaceuticals
Regenerative Medicine Market, By Application:
Cardiovascular
Oncology
Musculoskeletal
Wound Healing
Ophthalmology
Others
Regenerative Medicine Market, By End User:
Hospitals
Specialty Centres
Academic & Research Institutes
Regenerative Medicine Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Regenerative Medicine Market.
Available Customizations:
Global Regenerative Medicine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Regenerative Medicine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapy (Stem Cell Therapy, Gene Therapy, Tissue Engineering, And Small Molecule & Biologic)
5.2.2. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, And Pharmaceuticals)
5.2.3. By Application (Cardiovascular, Oncology, Musculoskeletal, Wound Healing, Ophthalmology, And Others)
5.2.4. By End User (Hospitals, Specialty Centres, Academic & Research Institutes)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Regenerative Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy
6.2.2. By Material
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Regenerative Medicine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapy
6.3.1.2.2. By Material
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Regenerative Medicine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapy
6.3.2.2.2. By Material
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Regenerative Medicine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapy
6.3.3.2.2. By Material
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Regenerative Medicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Material
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Regenerative Medicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Material
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. United Kingdom Regenerative Medicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Material
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Italy Regenerative Medicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Therapy
7.3.3.2.2. By Material
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. France Regenerative Medicine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy
7.3.4.2.2. By Material
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Regenerative Medicine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy
7.3.5.2.2. By Material
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Regenerative Medicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Material
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Regenerative Medicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Material
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Regenerative Medicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Material
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Regenerative Medicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Material
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Regenerative Medicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Material
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Regenerative Medicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Material
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Regenerative Medicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Material
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Regenerative Medicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Material
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Regenerative Medicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Material
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Regenerative Medicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Material
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Regenerative Medicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Material
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Regenerative Medicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Material
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Regenerative Medicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Material
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Regenerative Medicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Material
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Global Regenerative Medicine Market: SWOT Analysis
14. Competitive Landscape
14.1. Stryker Corporation
14.2. Athersys, Inc.
14.3. Integra Lifesciences Corporation
14.4. Isto Biologics (Isto Biologics Medical Systems, Inc.)
